BMO
ZBH icon

Beck Mack & Oliver’s Zimmer Biomet ZBH Stock Holding History

Beck Mack & Oliver’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-2,947
Closed -$214K – 361
2013
Q2 		$214K Buy
+2,947
New +$220K 0.01% 323

Other funds holding ZBH

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
IFP
Independent Franchise Partners London, United Kingdom $14.3B AUM 3.49% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Beck Mack & Oliver's ZBH Position: Q3 2013 in Review

Beck Mack & Oliver sold out of Zimmer Biomet (ZBH) in Q3 2013, closing a stake of 2,947 shares — an estimated $214K sold.

Beck Mack & Oliver first reported a position in ZBH in Q2 2013 and held it in 1 quarter. The position peaked at $214K in Q2 2013. 650 funds tracked by Wall St. Rank hold ZBH as of Q3 2013.

  • Beck Mack & Oliver reported no remaining Zimmer Biomet position as of Q3 2013 after selling out during the quarter.
  • Beck Mack & Oliver sold 2,947 Zimmer Biomet shares in Q3 2013, an estimated $214K.
  • Beck Mack & Oliver first reported a position in Zimmer Biomet in Q2 2013 and held it in 1 quarter.
  • Beck Mack & Oliver's Zimmer Biomet position peaked at $214K in Q2 2013.
  • 650 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2013.

Based on Beck Mack & Oliver's 13F filing for Q3 2013, filed 28 Oct 2013.